NCT01533532View on ClinicalTrials.gov

A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2)

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

Not specified

Conditions
Endometriosis
Interventions
DRUG

KLH-2109

DRUG

KLH-2109

DRUG

KLH-2109

DRUG

placebo

Trial Locations (1)

Unknown

Japan, Tokyo and Other Japanese City

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT01533532 - A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2) | Biotech Hunter | Biotech Hunter